Clinical Trial Update: BrUOG L301 With Non-Small Cell Lung Cancer and Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update for BrUOG L301 in non-small cell lung cancer with bone metastases; study status is completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer with Bone Metastases

Snippet

Sponsor: Angela Taber MD | Conditions: Non Small Cell Lung Cancer With Bone Metastatses | Phase 2 | Status: COMPLETED | Results posted: 2018-06-08